As their use expands, questions naturally arise about potential side effects, including whether GLP-1 drugs cause blood clots
This syndrome is characterized by clinical symptoms of sickness behavior such as leaden paralysis of the limbs, hypersomnia, and hyperphagia/weight gain, while mood reactivity is unimpaired, i.e., mood brightens in response to positive events (according to DSM-5 criteria for MDD with atypical features), while still suffering from lack of concentration and higher levels of exhaustibility as in melancholic MDD [99]
Eliminating excess stored fat and releasing it to be used as energy can lead to naturally better weight management and balanced body composition
Semaglutide primarily works through the GLP-1 receptor pathway, helping support satiety, appetite regulation, food noise reduction, and glucose-related signaling